127 related articles for article (PubMed ID: 26005408)
1. Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.
Impellizzeri AA; Pappalardo M; Basile L; Manfra O; Andressen KW; Krobert KA; Messina A; Levy FO; Guccione S
Front Behav Neurosci; 2015; 9():92. PubMed ID: 26005408
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
Canal CE; Cordova-Sintjago TC; Villa NY; Fang LJ; Booth RG
Eur J Pharmacol; 2011 Dec; 673(1-3):1-12. PubMed ID: 22020288
[TBL] [Abstract][Full Text] [Related]
4. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl.
Tian X; Zhang J; Wang S; Gao H; Sun Y; Liu X; Fu W; Tan B; Su R
Front Pharmacol; 2022; 13():919325. PubMed ID: 36120357
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
[TBL] [Abstract][Full Text] [Related]
7. New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.
Rivail L; Giner M; Gastineau M; Berthouze M; Soulier JL; Fischmeister R; Lezoualc'h F; Maigret B; Sicsic S; Berque-Bestel I
Br J Pharmacol; 2004 Oct; 143(3):361-70. PubMed ID: 15351779
[TBL] [Abstract][Full Text] [Related]
8. Human Serotonin 5-HT
Rdova-Sintjago TC; Villa N; Canal C; Booth R
Int J Quantum Chem; 2012 Jan; 112(1):. PubMed ID: 24244046
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1.
Manfra O; Van Craenenbroeck K; Skieterska K; Frimurer T; Schwartz TW; Levy FO; Andressen KW
ACS Chem Neurosci; 2015 Jul; 6(7):1206-18. PubMed ID: 25706089
[TBL] [Abstract][Full Text] [Related]
10. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.
Zhong M; Navratil AM; Clay C; Sanborn BM
Biochemistry; 2004 Mar; 43(12):3490-8. PubMed ID: 15035619
[TBL] [Abstract][Full Text] [Related]
11. Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs.
Bruheim S; Krobert KA; Andressen KW; Levy FO
Recept Channels; 2003; 9(2):107-16. PubMed ID: 12916471
[TBL] [Abstract][Full Text] [Related]
12. Preassociation between the 5-HT
Ulsund AH; Dahl M; Frimurer TM; Manfra O; Schwartz TW; Levy FO; Andressen KW
FASEB J; 2019 Mar; 33(3):3870-3886. PubMed ID: 30508496
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the mouse 5-HT7 receptor: importance of the third intracellular loop for receptor-G-protein interaction.
Obosi LA; Hen R; Beadle DJ; Bermudez I; King LA
FEBS Lett; 1997 Jul; 412(2):321-4. PubMed ID: 9256244
[TBL] [Abstract][Full Text] [Related]
14. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Boess FG; Monsma FJ; Sleight AJ
J Neurochem; 1998 Nov; 71(5):2169-77. PubMed ID: 9798944
[TBL] [Abstract][Full Text] [Related]
16. Serotonin (5-HT7) receptor-stimulated activation of cAMP-PKA pathway in bovine corneal epithelial and endothelial cells.
Grueb M; Rohrbach JM; Schlote T; Mielke J
Ophthalmic Res; 2012; 48(1):22-7. PubMed ID: 22222787
[TBL] [Abstract][Full Text] [Related]
17. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations.
Prioleau C; Visiers I; Ebersole BJ; Weinstein H; Sealfon SC
J Biol Chem; 2002 Sep; 277(39):36577-84. PubMed ID: 12145300
[TBL] [Abstract][Full Text] [Related]
18. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
Boess FG; Monsma FJ; Meyer V; Zwingelstein C; Sleight AJ
Mol Pharmacol; 1997 Sep; 52(3):515-23. PubMed ID: 9284367
[TBL] [Abstract][Full Text] [Related]
19. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
